Researchers, federal employees, and members of the public have voiced concerns about restrictions recently placed on federal ...

Burnout in US oncologists has increased over the past 10 years, according to results of 2 surveys. 1 Researchers compared results of a 2023 survey of 328 oncologists to results of a 2013 survey of ...

A growing body of research suggests that exposure to PFAS, commonly called "forever chemicals," may increase a person's risk ...

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

Neoadjuvant CRT plus sintilimab yielded a higher pCR rate than neoadjuvant chemo plus sintilimab in patients with locally ...

States and the nation’s health industry were thrown into disarray after the Trump administration ordered that the government freeze nearly all federal grants at 5 pm ET on Tuesday.

Incorporating mpMRI into initial staging before TURBT reduces the time to correct treatment for patients with MIBC.

New research suggests that firstborn twins may have a greater risk of developing leukemia than second-born twins.

The FDA has approved Enhertu (fam-trastuzumab deruxtecan-nxki) for HR-positive, HER2-low or HER2-ultralow metastatic breast cancer.

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

(HealthDay News) — Young adults with cancer may have a higher risk of death if they live in historically redlined neighborhoods, according to a study published in Cancer.

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.